Results of BARD1 ovarian cancer study
Filed with ASX · · 3 pages · English
Earlier from Inoviq
- Research and Development Update
- Appendix 4E Preliminary Financial Results
- Publication of BARD1 Lung Cancer Test
- Australian Patent Issued
- Shareholder Update
Later from Inoviq
- Grant of Japanese Patent
- Additional BARD1 Ovarian Test Results
- Israeli Patent Issued in Bard1 Core Patent Family
- Capital Raising
- Voluntary Suspension
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq